BTK Inhibitor Compounds Modulating Enzymatic Activity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a significant need for effective inhibitors of Bruton's tyrosine kinase (Btk) due to its critical role in B-cell signaling and its association with various human diseases, including autoimmune disorders and cancers, where current solutions are inadequate.
Innovation Solution
Development of specific compounds represented by Formula (I) or their pharmaceutically acceptable salts, which act as Btk modulators and inhibitors, administered to treat disorders responsive to Btk inhibition.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing Btk inhibitors are used, then some inhibition effect is achieved, but the inhibitors are insufficiently effective for treating autoimmune disorders and cancers
Solution Approach 1:
The patent applies parameter changes by systematically varying chemical parameters of the Btk inhibitor molecules, including substituting different heteroatoms (N, O, S) at specific positions in the molecular structure, adjusting side chain lengths and configurations, and modifying functional groups to enhance binding affinity and enzymatic inhibition effectiveness against Btk
Solution Approach 2:
The patent employs composite materials by combining multiple functional moieties within the Btk inhibitor molecules, integrating heteroaryl groups, carbonyl structures, and various side chains to create composite molecular entities that achieve superior inhibition effectiveness compared to simple single-functional inhibitors
2Reliability
If more potent Btk inhibitors are developed, then treatment effectiveness improves, but the complexity of compound synthesis and characterization increases
Solution Approach 1:
The patent applies segmentation by dividing the Btk inhibitor molecular structure into distinct functional segments: a core heteroaryl group, carbonyl linkage, side chain moieties, and terminal functional groups. This segmentation allows independent optimization of each segment's contribution to binding affinity while simplifying the overall synthesis process through modular assembly
Solution Approach 2:
The patent employs universality by designing a core molecular framework that can accommodate multiple different side chains and heteroatom substitutions, allowing a single base structure to generate multiple potent inhibitors with different specificities and potency levels, thereby reducing the need to develop entirely new molecular cores for each application
Data Source
AI summary
Provided are compounds of Formula (I) or pharmaceutically acceptable salts thereof, wherein the variables in Formula (I) are as defined herein; and methods for their use and production.